论文部分内容阅读
目的:观察参芪扶正注射液在辅助脑转移瘤患者化疗中的临床疗效。方法:将68例脑转移瘤患者随机分为两组,参芪加化疗组(治疗组)36例,单用化疗组(对照组)32例,两组均观察3个周期。结果:两组近期疗效比较差异无显著性,但治疗组生活质量较对照组有明显改善,并且治疗组患者的机体免疫功能有所提高。结论:在化疗同时配合使用参芪扶正注射液,可提高患者免疫功能,改善全身状态,增强患者对化疗的耐受性,从而提高疗效和患者的生存质量。
Objective: To observe the clinical effect of Shenqi Fuzheng injection in the chemotherapy of patients with brain metastases. Methods: Sixty-eight patients with brain metastases were randomly divided into two groups: 36 cases in Shenqi plus chemotherapy group (treatment group), 32 cases in chemotherapy alone group (control group), and 3 cycles in both groups. Results: There was no significant difference in short-term curative effect between the two groups, but the quality of life in the treatment group was significantly improved compared with the control group, and the immune function of the treatment group was improved. Conclusion: The combination of Shenqi Fuzheng injection with chemotherapy can improve immune function, improve the whole body condition and enhance patient tolerance to chemotherapy, so as to improve curative effect and quality of life of patients.